Skip to content
DraconiticResearch
Search Sources API
190,335 studies31 sourcesUpdated 20 min ago
PreprintAll rights reservedmedRxiv

Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer

  • M. Jiang
  • D. Zhang
  • Y.-C. Hsueh
  • Y. Zhao
  • S. Zhao
  • Q. Zhang
  • M. Huang
  • P. Gao
  • X. Liu
  • Y. Liu
  • Q. Jin
  • W. Dong
9 more authors
  • J. Zhang
  • R. Ran
  • R. Zhang
  • Y. Fan
  • J. Xu
  • G. Tan
  • C. Zhang
  • C. Zhang
  • G. Niu1
  1. 1Phil Rivers Technology Ltd, Beijing, China
Read full textPDFDOICite

Related

  1. Efficacy of Negative Pressure Suction‐Assisted Flexible Ureteroscopy for Upper Urinary Tract Calculi and Construction of a Stone‐Free Rate Prediction Model
    Ren‐Hui Qiu, Ding‐Sheng He, Chun‐Yu Guo +2
    The Kaohsiung journal of medical sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis
    Chunle Hu, Li Zhan, Yanhui Li +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Nanoparticle‐Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple‐Negative Breast Cancer by Modulating RAB7A Ubiquitination‐Associated Stability and Autophagy
    Wei Hu, Qishuai Chen, Yan Ma +7
    Advanced SciencePeer-reviewedCC BY 4.0Full text1 citedEpidemiology & public healthPMC
  4. Sampling composition and sequencing effort in the detection of within-hospital Gram-negative genomic clustering: a prospective observational study at two tertiary-care hospitals
    L. Knegendorf, J. Erdmann, K. L. Nielsen +5
    medRxivPreprintAll rights reservedFull textInfectious diseasemedRxiv
  5. The Prognostic Role of Vimentin Expression in Triple‐Negative Breast Cancer: A Retrospective Cohort Study
    Erwin Danil Yulian, Tantri Hellyanti, Karl Heinz Leonhardt Rowika
    Cancer reports (Hoboken, N.J.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{jiang2026prediction,
  title = {{Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer}},
  author = {M. Jiang and D. Zhang and Y.-C. Hsueh and Y. Zhao and S. Zhao and Q. Zhang and M. Huang and P. Gao and X. Liu and Y. Liu and Q. Jin and W. Dong and J. Zhang and R. Ran and R. Zhang and Y. Fan and J. Xu and G. Tan and C. Zhang and C. Zhang and G. Niu},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.30.26364376},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.30.26364376v1},
}
RIS
TY  - UNPB
TI  - Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer
AU  - M. Jiang
AU  - D. Zhang
AU  - Y.-C. Hsueh
AU  - Y. Zhao
AU  - S. Zhao
AU  - Q. Zhang
AU  - M. Huang
AU  - P. Gao
AU  - X. Liu
AU  - Y. Liu
AU  - Q. Jin
AU  - W. Dong
AU  - J. Zhang
AU  - R. Ran
AU  - R. Zhang
AU  - Y. Fan
AU  - J. Xu
AU  - G. Tan
AU  - C. Zhang
AU  - C. Zhang
AU  - G. Niu
PY  - 2026
DA  - 2026/09/30
PB  - medRxiv
DO  - 10.64898/2026.09.30.26364376
UR  - https://www.medrxiv.org/content/10.64898/2026.09.30.26364376v1
ER  -